Rudd Co d/b/a Styre Wealth’s Novo Nordisk NVO Stock Holding History

Rudd Co d/b/a Styre Wealth’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.15M	Buy	+55,848	New	+$2.57M	2.09%	5

Other funds holding NVO

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

Corda Investment Management Houston, Texas $1.52B AUM 30.53% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Philip James Wealth Mangement Milton, Georgia $906M AUM 30.39% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.36B AUM 20.86% 1-Year Est. Return

Cullen/Frost Bankers San Antonio, Texas $10.2B AUM 22.58% 1-Year Est. Return

Rudd Co d/b/a Styre Wealth's NVO Position: Q3 2026 in Review

Rudd Co d/b/a Styre Wealth opened a new position in Novo Nordisk (NVO) in Q3 2026: 55,848 shares worth $2.15M. The stake represents 2.09% of the portfolio and ranks #5 among its holdings.

467 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Rudd Co d/b/a Styre Wealth held 55,848 shares of Novo Nordisk worth $2.15M as of Q3 2026.
Novo Nordisk was a new Rudd Co d/b/a Styre Wealth position in Q3 2026.
Novo Nordisk made up 2.09% of Rudd Co d/b/a Styre Wealth's portfolio in Q3 2026, its #5 holding.
467 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Rudd Co d/b/a Styre Wealth's 13F filing for Q3 2026, filed 29 Oct 2026.